ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
iPremom, a Spanish molecular diagnostics company, raised €15 million in Seed funding for its MaiRa platform, which analyzes blood tests for early first-trimester pregnancy complication signals. Amadeus Capital Partners led the round, with Asabys Partners and APEX Ventures participating. The funding supports clinical validation and commercial rollout.
Tap to vote and see what everyone thinks.
Summary by ByteBrief